CompletedPhase 4

Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques

Iraq60 participantsStarted 2023-01-04

Plain-language summary

The goal of this clinical trial is to evaluate the dental lasers as an alternative of chemical medicaments used in the pulpotomy procedures. The main question it aims to answer is: • Lasers pulpotomies are a viable alternative to the standard Formocresol and Sodium Hypochlorite medicaments. All participants groups (Formocresol, Sodium Hypochlorite, Diode and Er:Cr;YSGG lasers) for pulpotomy procedure will follow the same clinical protocol, except for the techniques that will be used for hemostasis of the pulpotomies which either will be achieved by Formocresol or Sodium Hypochlorite solutions or by Diode or Erbium lasers.

Who can participate

Age range4 Years – 8 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Deep carious lesions present in primary molars. * No history of spontaneous or persistent pain. * Lack of clinical evidence of pulpal degeneration, such as pain on percussion, history of swelling or sinus tracts. * Restorable teeth following completion of the procedure. * Absence of radiographic signs and symptoms of pulpal degeneration. * Following pulpal amputation, hemostasis could be easily achievable. Exclusion Criteria: * Uncooperative children. * Children with medically compromised disease. * Presence of radiographical signs and symptoms of pulpal degeneration. * Physiologic root resorption is more than one-third.

What they're measuring

Evaluation of clinical and radiographical success rate of pulpotomy procedure of FC, and NaOCl techniques and two different types of lasers Diode and Erbium Cr,YSGG lasers

Timeframe: one year

Trial details

NCT IDNCT06002646

SponsorUniversity of Sulaimani

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-08